Evidence map›Paper›PMID 31138649›Full record

ArticleThe Journal of biological chemistry2019

p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration.

Shiela C Samson, Andrew Elliott, Brian D Mueller, Yung Kim, Keith R Carney, Jared P Bergman, John Blenis, Michelle C Mendoza

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Platelet-derived growth factor receptor alpha regulates fetal testis differentiation via an ERK-CREB axis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. N2B27 media formulations influence gastruloid development.Development (Cambridge, England) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. ERK signaling for cell migration and invasion.Frontiers in molecular biosciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shiela C SamsonDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and.
Andrew ElliottDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and.
Brian D MuellerDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and.
Yung KimDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and.
Keith R CarneyDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and.
Jared P BergmanDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and.
John BlenisDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.
Michelle C MendozaDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112 and; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115. Electronic address: Michelle.Mendoza@hci.utah.edu.
University of Utah · USHarvard University · US

Funding

ONCOGENIC REGULATION OF S6 PROTEIN KINASE &CELL GROWTHR01CA046595 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOHN BLENIS · 1988 to 2026
$10.6M
Regulation of Cell Motility by the Oncogenic ERK-MAPK PathwayK01CA168850 · NCI · UNIVERSITY OF UTAH · PI MENDOZA, MICHELLE CHRISTINE · 2012 to 2016
$690k
The Role and Regulation of Lymphocyte Oriented Kinase in RAS-driven Cancer InvasionF32CA236428 · NCI · UNIVERSITY OF UTAH · PI BERGMAN, JARED PETER · 2019 to 2020
$118k
NCI NIH HHS F32 CA236428NCI NIH HHS K01 CA168850NCI NIH HHS R01 CA046595
6 · The paper itself

Abstract

Cell migration is essential to embryonic development, wound healing, and cancer cell dissemination. Cells move via leading-edge protrusion, substrate adhesion, and retraction of the cell's rear. The molecular mechanisms by which extracellular cues signal to the actomyosin cytoskeleton to control these motility mechanics are poorly understood. The growth factor-responsive and oncogenically activated protein extracellular signal-regulated kinase (ERK) promotes motility by signaling in actin polymerization-mediated edge protrusion. Using a combination of immunoblotting, co-immunoprecipitation, and myosin-binding experiments and cell migration assays, we show here that ERK also signals to the contractile machinery through its substrate, p90 ribosomal S6 kinase (RSK). We probed the signaling and migration dynamics of multiple mammalian cell lines and found that RSK phosphorylates myosin phosphatase-targeting subunit 1 (MYPT1) at Ser-507, which promotes an interaction of Rho kinase (ROCK) with MYPT1 and inhibits myosin targeting. We find that by inhibiting the myosin phosphatase, ERK and RSK promote myosin II-mediated tension for lamella expansion and optimal edge dynamics for cell migration. These findings suggest that ERK activity can coordinately amplify both protrusive and contractile forces for optimal cell motility.

Indexed as

Actin CytoskeletonActomyosinAnimalsCell LineCell MovementChlorocebus aethiopsCOS CellsCytoskeletonHumansMAP Kinase Signaling SystemMuscle ContractionMyosin-Light-Chain PhosphataseMyosinsPhosphorylationProtein Bindingrho-Associated KinasesActomyosinMyosin-Light-Chain PhosphataseMyosinsPPP1R12A protein, humanrho-Associated KinasesRibosomal Protein S6 Kinases, 90-kDaROCK1 protein, humancell migrationcell motilitycell signalingcytoskeletonextracellular-signal-regulated kinase (ERK)myosinmyosin phosphatase targeting subunit (MYPT1)p90 ribosomal S6 kinase (RSK)Rho kinase (ROCK)

Identifiers

PMID31138649
PMCPMC6635457
OpenAlexW2947065889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.